At 26th March 2025
- Perspectives: As police step back from mental health calls, telepsychiatry steps forward
- Breaking: 23andMe files for Chapter 11 bankruptcy–whither customer data and security? An impact similar to Theranos?
- Short takes: interesting takeaways from the Veradigm earnings call, VA cuts ~6 EHRM contracts; mergers for DispatchHealth-Medically Home, Wysa-April Health
- News roundup: NHS England to be abolished, absorbed into UK DHSC, while IT glitch shorts 5,200 from screenings; Veradigm *finally* files 2022 financials (updated), VA-Oracle EHR now promises 13 installs in 2026
- Breaking: Stefano Pessina to near-double stake in Walgreens after Sycamore Partners takeover–reports
- Can kicked down road: telehealth flexibilities extended to 30 September
- Perspectives: Telehealth Expands Access to Addiction Treatment and Specialized Care, But Navigating Regulations Remains Key
- Breaking: telehealth nutrition provider Foodsmart taps former Amwell COO Kurt Knight as CEO
- News roundup: MSK is ‘it’ with Hinge Health’s IPO filing, Vori Health’s $53M raise, Dario Health’s 33% revenue increase; CoachCare buys VitalTech, ModMed investor sells majority stake, Health NZ uses Excel–only; Holmes gets rehearing extension
- Sycamore Partners taking on 83% debt in financing their Walgreens leveraged buyout–some observations
- Update: Wojcicki increases 23andMe per share offer to $2.94 from $0.41–but there’s three contingency ‘catches’, and more
- Perspectives: How the DEA Telehealth Extension Impacts Patient Access to Opioid Use Disorder Treatments & Buprenorphine Prescriptions
Most Recent Comments